CADL
Candel Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.08 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: 100% Strong Buy from two analysts with 66.7%–100% historical win rates. Fund‑flow score 7.69 is good, showing overall inflow, though Small and Medium blocks are negative. Combined, the outlook leans strongly positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-13
InstitutionCanaccord Genuity
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for CADL?
- CADL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.08/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
